Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients

Update Il y a 5 ans
Reference: NCT01822340

Woman and Man

  • | Country :
  • Hungary
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to assess the safety, tolerability and Pharmacokinetic/ Pharmacodynamic (PK/PD) profile of three doses of HM10560A on an every week (EW) regime and one dose on every other week (EOW) regime administered for a period of 24 weeks initial study.


Inclusion criteria

  • Adult Growth Hormone Deficiency

Links